Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: A retrospective study of the incidence, clinical features, and outcome

Transplantation

Volumn 88, Issue 10, 2009, Pages 1222-1226

  Avetisyan, Gayane ^a   Mattsson, Jonas ^a   Sparrelid, Elda ^a   Ljungman, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hematopoietic stem cell transplantation.; Respiratory syncytial virus

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS SHEDDING;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 73849136362     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bb477e     Document Type: Article

References (23)

1. Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10: 224.
2. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: Evidence for asymptomatic parainfluenza virus infection. Blood 2007; 110: 1681.
3. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: A prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479.
4. Bowden RA. Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center experience. Am J Med 1997; 102: 27; discussion 42.
5. Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001; 7(suppl): 11S.
6. Ghosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751.
7. Ljungman P. Respiratory virus infections in stem cell transplant patients: The European experience. Biol Blood Marrow Transplant 2001; 7(suppl): 5S.
8. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: Single-center study and review of the literature. Clin Infect Dis 2008; 46: 402.
9. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: The European perspective. Am J Med 1997; 102: 44.
10. Erard V, Chien JW, Kim HW, et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: The role of community respiratory viruses. J Infect Dis 2006; 193: 1619.
11. Sparrelid E, Ljungman P, Ekelöf-Andstrom E, et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19: 905.
12. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778.
13. Lee I, Barton TD. Viral respiratory tract infections in transplant patients: Epidemiology, recognition, and management. Drugs 2007; 67: 1411.
14. Abdallah A, Rowland KE, Schepetiuk SK, et al. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: Effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant 2003; 32: 195.
15. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: A retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278.
16. Boeckh M, Berrey MM, Bowden RA, et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 2001; 184: 350.
17. DeVincenzo JP, Hirsch RL, Fuentes RJ, et al. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation-A compassionate use experience. Bone Marrow Transplant 2000; 25: 161.
18. Small TN, Casson A, Malak SF, et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 321.
19. Cassimos DC, Tsalkidis A, Tripsianis GA, et al. Asthma, lung function and sensitization in school children with a history of bronchiolitis. Pediatr Int 2008; 50: 51.
20. Piippo-Savolainen E, Remes S, Kannisto S, et al. Asthma and lung function 20 years after wheezing in infancy: Results from a prospective follow-up study. Arch Pediatr Adolesc Med 2004; 158: 1070.
21. Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178: 876.
22. Kumar D, Erdman D, Keshavjee S, et al. Clinical impactof community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5: 2031.
23. Castilow EM, Olson MR, Varga SM. Understanding respiratory syncy-tial virus (RSV) vaccine-enhanced disease. Immunol Res 2007; 39: 225.